ScienceMore in Science→
Senescence-Targeted Nanotherapy Curbs Fibrosis and Tumor Immune Exclusion
Key Takeaways
- A Science paper (Volume 393, Issue 6818, September 2026) describes a senescence-directed nanotherapy that ameliorates fibrosis and overcomes immune exclusion in cancer.
- The work links three fields: senescence biology, nanoparticle drug delivery, and tumor immunology.
- Senescent cells resist death, secrete inflammatory signals, remodel matrix tissue, and can shape local immune activity.
- Fibrosis both scars organs and forms a stroma barrier inside tumors that limits drug and immune penetration.
DE
DT Editorial Team··via science.org